成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 13726-84-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 13726-84-6
Chemical Structure| 13726-84-6
Structure of 13726-84-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 13726-84-6 ]

Related Doc. of [ 13726-84-6 ]

Alternatived Products of [ 13726-84-6 ]
Product Citations

Product Details of [ 13726-84-6 ]

CAS No. :13726-84-6 MDL No. :MFCD00038257
Formula : C14H25NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :YGSRAYJBEREVRB-VIFPVBQESA-N
M.W : 303.35 Pubchem ID :6993432
Synonyms :

Calculated chemistry of [ 13726-84-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.79
Num. rotatable bonds : 10
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 77.02
TPSA : 101.93 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.48
Log Po/w (XLOGP3) : 1.72
Log Po/w (WLOGP) : 2.09
Log Po/w (MLOGP) : 1.34
Log Po/w (SILICOS-IT) : 1.22
Consensus Log Po/w : 1.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.14
Solubility : 2.18 mg/ml ; 0.00717 mol/l
Class : Soluble
Log S (Ali) : -3.48
Solubility : 0.101 mg/ml ; 0.000334 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.95
Solubility : 3.4 mg/ml ; 0.0112 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.41

Safety of [ 13726-84-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13726-84-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13726-84-6 ]

[ 13726-84-6 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 130333-58-3 ]
  • [ 13726-84-6 ]
  • 2
  • [ 13726-84-6 ]
  • [ 74-88-4 ]
  • (R)-2-tert-Butoxycarbonylamino-pentanedioic acid 5-tert-butyl ester 1-methyl ester [ No CAS ]
  • 3
  • [ 13726-84-6 ]
  • [ 62-53-3 ]
  • [ 179083-21-7 ]
  • 4
  • [ 13726-84-6 ]
  • [ 179082-63-4 ]
  • 5
  • [ 13726-84-6 ]
  • [ 179083-28-4 ]
  • 6
  • [ 13726-84-6 ]
  • (R)-4-[Isopropyl-(4-methoxy-phenyl)-carbamoylmethyl]-phenyl-carbamoyl}-4-(3-phenyl-ureido)-butyric acid [ No CAS ]
  • 7
  • [ 13726-84-6 ]
  • [ 179083-22-8 ]
  • 8
  • [ 24424-99-5 ]
  • [ 13726-84-6 ]
  • 9
  • [ 91103-36-5 ]
  • [ 13726-84-6 ]
  • 10
  • [ 129016-13-3 ]
  • [ 13726-84-6 ]
  • 11
  • [ 129016-14-4 ]
  • [ 13726-84-6 ]
  • 12
  • 2-deoxy-2<<(1,1-dimethylethoxy)carbonyl>amino>-D-glucopyranose [ No CAS ]
  • [ 13726-84-6 ]
  • 13
  • [ 98102-32-0 ]
  • [ 13726-84-6 ]
  • 14
  • [ 13726-84-6 ]
  • [ 130333-58-3 ]
YieldReaction ConditionsOperation in experiment
18.1 18.2 l,l-Dimethylethyl (4i)-4-([(l,l-dimethylethyl)oxy]carbonyl}amino)-5-hydroxypentanoate: [00220] Triethylamine (11.49 mL, 82.4 mmol) and ethyl chloroformate (8.27 niL, 86.5 mmol) were added successively by syringe to 2V-t-BOC-D-glutamic acid 5-tert-bviotatyl ester (25 g, 82.4 mmol) in THF (588 mL) at <0 0C (ice-salt bath). After stirring in the cold bath for 40 min, solids were filtered and washed with THF (150 mL). The filtrate was transferred to a 250-mL addition funnel and added to a solution of sodium borohydride (8.42 g, 222.5 mmol) in H2O (114 mL) at 00C over 1 hour. The reaction mixture was maintained at 0 0C for 1.5 h and then stirred for 16 h (00C to room temperature). After the bulk of solvents were removed by rotary evaporation, the concentrate was quenched with ice water (50 mL) and 1 N HCl (50 mL). After extraction with EtOAc (4 x 100 mL), the extracts were washed with 100 mL: 0.5 M citric acid, saturated NaHCO3, H2O, and brine and concentrated in vacuo to give the title compound, which was used directly in the next step. ESMS [M+H]+ = 290.4, [2M+H]+ = 579.4. (Literature prep: J. Med. Chan, 1999, 42(1), 95-108 for other isomer).
  • 15
  • C30H38FN5O7S [ No CAS ]
  • [ 13726-84-6 ]
  • C44H61FN6O12S [ No CAS ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; GENERAL PROCEDURE FOR THE COUPLING OF AMINES WITH CARBOXYLIC ACIDS: The compound is dissolved in an appropriate amount of dichloromethane and the carboxylic acid (1.1 equiv.) added followed by PS-CDI (2 equiv.) and DIEA (10 equiv.). The reaction is shaken at room temperature until the starting material has been consumed. Once complete, the reaction is filtered and the filtrate concentrated in vacuo to obtain the crude product. In most cases, the crude product is pure enough for further transformations. If the crude product is not sufficiently pure, it can be purified using normal or reverse phase chromatography.
  • 16
  • [ 865997-30-4 ]
  • [ 13726-84-6 ]
  • (4R)-4-amino-5-{2-[({1-butyl-4-[([4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-yl}carbonyl)amino]ethoxy}-5-oxopentanoic acid hydrochloride [ No CAS ]
Recommend Products
Same Skeleton Products
Historical Records
; ;